enGene Therapeutics Inc.
Biological Products, (No Diagnostic Substances) | SIC: 2836Phone: (514) 332-4888
State of Inc.: Z4
- Nasdaq:ENGN
- Nasdaq:ENGNW
Form: 10-Q
Filing Date: 09 Mar 2026Report Date: 31 Jan 2026
Accepted: 09 Mar 2026 05:09 a.m.
Accession Number: 0001193125-26-097541
File Number: 001-41854
Film Number: 26733163
Documents
Primary Document: 10-Q
Accepted: 09 Mar 2026 05:09 a.m.
0001193125-26-097541-index-headers.html
Last Modified: 09 Mar 2026 05:09 a.m.
0001193125-26-097541-index.html
Last Modified: 09 Mar 2026 05:09 a.m.
0001193125-26-097541.txt
Last Modified: 09 Mar 2026 05:09 a.m.
0001193125-26-097541-xbrl.zip
Last Modified: 09 Mar 2026 05:09 a.m.
engn-20260131.xsd
Last Modified: 09 Mar 2026 05:09 a.m.
engn-20260131_htm.xml
Last Modified: 09 Mar 2026 05:09 a.m.
engn-ex31_1.htm
Last Modified: 09 Mar 2026 05:09 a.m.
engn-ex31_2.htm
Last Modified: 09 Mar 2026 05:09 a.m.
engn-ex32_1.htm
Last Modified: 09 Mar 2026 05:09 a.m.
engn-ex32_2.htm
Last Modified: 09 Mar 2026 05:09 a.m.
FilingSummary.xml
Last Modified: 09 Mar 2026 05:09 a.m.
MetaLinks.json
Last Modified: 09 Mar 2026 05:09 a.m.
R1.htm
Last Modified: 09 Mar 2026 05:09 a.m.
R10.htm
Last Modified: 09 Mar 2026 05:09 a.m.
R11.htm
Last Modified: 09 Mar 2026 05:09 a.m.
R12.htm
Last Modified: 09 Mar 2026 05:09 a.m.
R13.htm
Last Modified: 09 Mar 2026 05:09 a.m.
R14.htm
Last Modified: 09 Mar 2026 05:09 a.m.
R15.htm
Last Modified: 09 Mar 2026 05:09 a.m.
R16.htm
Last Modified: 09 Mar 2026 05:09 a.m.
R17.htm
Last Modified: 09 Mar 2026 05:09 a.m.
R18.htm
Last Modified: 09 Mar 2026 05:09 a.m.
R19.htm
Last Modified: 09 Mar 2026 05:09 a.m.
R2.htm
Last Modified: 09 Mar 2026 05:09 a.m.